» Articles » PMID: 15207531

PLGA-PEI Nanoparticles for Gene Delivery to Pulmonary Epithelium

Overview
Specialty Pharmacology
Date 2004 Jun 23
PMID 15207531
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary gene delivery is thought to play an important role in treating genetically related diseases and may induce immunity towards pathogens entering the body via the airways. In this study we prepared poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles bearing polyethyleneimine (PEI) on their surface and characterized them for their potential in serving as non-viral gene carriers to the pulmonary epithelium. Particles that were synthesized at different PLGA-PEI ratios and loaded with DNA in several PEI-DNA ratios, exhibited narrow size distribution in all formulations, with mean particle sizes ranging between 207 and 231 nm. Zeta potential was strongly positive (above 30 mV) for all the PEI-DNA ratios examined and the loading efficiency exceeded 99% for all formulations. Internalization of the DNA-loaded PLGA-PEI nanoparticles was studied in the human airway submucosal epithelial cell line, Calu-3, and DNA was detected in the endo-lysosomal compartment 6 h after particles were applied. Cytotoxicity of these nanoparticles was dependent on the PEI-DNA ratio and best cell viability was achieved by PEI-DNA ratios 1:1 and 0.5:1. These findings demonstrate that PLGA-PEI nanoparticles are a potential new delivery system to carry genes to the lung epithelium.

Citing Articles

PLGA-Based Strategies for Intranasal and Pulmonary Applications.

Omidian H, Wilson R Pharmaceutics. 2025; 17(2).

PMID: 40006573 PMC: 11859611. DOI: 10.3390/pharmaceutics17020207.


Martini compatible coarse-grained model of polyethylenimine for pulmonary gene delivery.

Lunt G, Hashemi N, Mahajan S, Tang T Sci Rep. 2025; 15(1):4377.

PMID: 39910324 PMC: 11799348. DOI: 10.1038/s41598-025-88848-x.


Investigating the Formation of Polymer-Nanoparticle Complex Coacervate Hydrogels Using Polymerization-Induced Self-Assembly-Derived Nanogels with a Succinate-Functional Core.

Du R, Li X, Fielding L Langmuir. 2024; 40(39):20648-20656.

PMID: 39291829 PMC: 11447913. DOI: 10.1021/acs.langmuir.4c02626.


PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy.

Gonzalez-Melero L, Santos-Vizcaino E, Varela-Calvino R, Gomez-Tourino I, Asumendi A, Boyano M Drug Deliv Transl Res. 2024; 14(10):2788-2803.

PMID: 38427275 PMC: 11525302. DOI: 10.1007/s13346-024-01557-2.


Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles.

Lewis M, Soto M, Maier E, Wulfe S, Bakheet S, Obregon H Bioeng Transl Med. 2023; 8(6):e10580.

PMID: 38023707 PMC: 10658486. DOI: 10.1002/btm2.10580.


References
1.
Gautam A, Densmore C, Golunski E, Xu B, Waldrep J . Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther. 2001; 3(4):551-6. DOI: 10.1006/mthe.2001.0300. View

2.
Newman K, Elamanchili P, Kwon G, Samuel J . Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo. J Biomed Mater Res. 2002; 60(3):480-6. DOI: 10.1002/jbm.10019. View

3.
Jenkins R, McAnulty R, Hart S, Laurent G . Pulmonary gene therapy. Realistic hope for the future, or false dawn in the promised land?. Monaldi Arch Chest Dis. 2003; 59(1):17-24. View

4.
Stern M, Ulrich K, Geddes D, Alton E . Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther. 2003; 10(16):1282-8. DOI: 10.1038/sj.gt.3301994. View

5.
Haura E, Sotomayor E, Antonia S . Gene therapy for lung cancer. Mol Biotechnol. 2003; 25(2):139-48. DOI: 10.1385/MB:25:2:139. View